Jubilant Pharmova arm gets tentative USFDA approval for Pantoprazole Oral Suspension

Jubilant Pharmova subsidiary Jubilant Generics gets USFDA tentative nod for Pantoprazole Sodium Oral Suspension, final approval after patent expiry in Dec 2026, shares down over 10% in 6 months

Leave a Reply

Your email address will not be published. Required fields are marked *